[HTML][HTML] Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects
R Kraaijvanger, M Janssen Bonás… - Frontiers in …, 2020 - frontiersin.org
Sarcoidosis is a heterogeneous disease in terms of presentation, duration, and severity. Due
to this heterogeneity, it is difficult to align treatment decisions. Biomarkers have proved to be …
to this heterogeneity, it is difficult to align treatment decisions. Biomarkers have proved to be …
[HTML][HTML] Club cell secreted protein CC16: potential applications in prognosis and therapy for pulmonary diseases
Club cell secretory protein (CC16) is encoded by the SCGB1A1 gene. It is also known as
CC10, secretoglobin, or uteroglobin. CC16 is a 16 kDa homodimeric protein secreted …
CC10, secretoglobin, or uteroglobin. CC16 is a 16 kDa homodimeric protein secreted …
Neurosarcoidosis: clinical manifestations, investigation and treatment
DP Kidd - Practical Neurology, 2020 - pn.bmj.com
Sarcoidosis affects the nervous system in 10% of cases. When it does so it can affect any
part of the nervous system and with all degrees of severity. It forms part of the differential …
part of the nervous system and with all degrees of severity. It forms part of the differential …
[HTML][HTML] Sarcoidosis-related uveitis: a review
S Giorgiutti, R Jacquot, T El Jammal, A Bert… - Journal of clinical …, 2023 - mdpi.com
Sarcoidosis is an inflammatory disease that involves the eyes in 10–55% of cases,
sometimes without systemic involvement. All eye structures can be affected, but uveitis is the …
sometimes without systemic involvement. All eye structures can be affected, but uveitis is the …
Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review
Aim: Interstitial lung diseases (ILD) are a group of lung disorders characterized by interstitial
lung thickening. Krebs von den Lungen-6 (KL-6) is a molecule that is predominantly …
lung thickening. Krebs von den Lungen-6 (KL-6) is a molecule that is predominantly …
BAL biomarkers' panel for differential diagnosis of interstitial lung diseases
Bronchoalveolar lavage (BAL) is a useful procedure for differential diagnosis of interstitial
lung diseases (ILDs) and for identification of granulomatous lung diseases. We investigated …
lung diseases (ILDs) and for identification of granulomatous lung diseases. We investigated …
Transcriptomics of bronchoalveolar lavage cells identifies new molecular endotypes of sarcoidosis
M Vukmirovic, X Yan, KF Gibson… - European …, 2021 - Eur Respiratory Soc
Background Sarcoidosis is a multisystem granulomatous disease of unknown origin with a
variable and often unpredictable course and pattern of organ involvement. In this study we …
variable and often unpredictable course and pattern of organ involvement. In this study we …
New concepts in the pathogenesis of sarcoidosis
D Bennett, E Bargagli, RM Refini… - Expert Review of …, 2019 - Taylor & Francis
Introduction: The pathogenesis of sarcoidosis is not yet completely understood, although in
recent years our knowledge has made considerable progress. Areas covered: This review …
recent years our knowledge has made considerable progress. Areas covered: This review …
Personalized medicine in sarcoidosis: unravelling biomarkers for targeted care
J Francesqui, P Marrades… - Current opinion in …, 2023 - journals.lww.com
These findings have implications for clinical practice and research. The limitations of
established biomarkers underscore the need for improved diagnostic tools in sarcoidosis …
established biomarkers underscore the need for improved diagnostic tools in sarcoidosis …
NK and NKT-like cells in granulomatous and fibrotic lung diseases
Background The pathogenetic and regulatory roles of natural killer (NK) and natural killer T-
like cells in interstitial lung diseases (ILDs), fibrotic and granulomatous of unknown etiology …
like cells in interstitial lung diseases (ILDs), fibrotic and granulomatous of unknown etiology …